Better Obesity Drug Race: Novo Nordisk vs Lilly 2026
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
Creating a retirement plan for those over 50? Discover essential elements to include for a successful retirement strategy.
26,197 articlesIn the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
A top Deutsche Bank economist warns that AI’s productivity gains may take years to materialize. If returns lag, risin...
When Wells Fargo reports earnings, the spotlight isn’t just on per-share figures. The real story this quarter is net ...
Vet clinics are raising fees as fewer pet visits occur, turning pet ownership into a costlier proposition. The trend ...
Travel finally bounced back, and hotel owners like Host Hotels faced a new set of challenges and opportunities. This ...
Investors are eyeing OneSpan’s 2025 earnings as the company scales its digital identity and security solutions. This ...
A compact team aims to redefine payments by moving crypto cards onto an Ethereum layer-2. This deep dive explains how...
Peloton reports fresh restructuring amid a stubborn demand slump and rising costs. The destruction peloton continues ...
CEOs are shifting from a single forecast to multi-scenario, wartime-style planning to weather shocks. CFOs play a piv...
The FHFA has directed Fannie Mae to accept cryptocurrency as mortgage reserves, but a steep haircut on crypto holding...
Investors flooded crypto funds with $858M in inflows as lawmakers push a clarity-focused framework for stablecoins. T...
Investors eyes turn to NextNav as 2025 earnings loom. This guide breaks down what to watch, potential growth drivers,...